吉林大学学报(医学版) ›› 2026, Vol. 52 ›› Issue (4): 905-913.doi: 10.13481/j.1671-587X.20260403

• 基础研究 • 上一篇    下一篇

血管生成素样蛋白6对蛋氨酸和胆碱缺乏饮食诱导的小鼠肝脏脂质沉积的改善作用及其机制

温升聪1,邓娅娅*,张鑫铬,何佳怡#,孙雨萌*,朱井玲1,宋永顺2(),张云华1()   

  1. 1.新疆地方与民族高发病教育部重点实验室石河子大学医学院生化教研室,新疆 石河子 832002
    2.新疆维吾尔自治区克拉玛依市中心医院检验科,新疆 克拉玛依 834000
    *.石河子大学医学院2022级临床医学专业
    △.石河子大学医学院2022级口腔医学专业
    #.石河子大学医学院2024级影像学专业
  • 收稿日期:2025-10-18 接受日期:2025-12-02 出版日期:2026-07-28 发布日期:2026-07-27
  • 通讯作者: 宋永顺,张云华 E-mail:1521003011@qq.com;yunhuazhang@shzu.edu.cn
  • 作者简介:温升聪(1999-),男,江西省吉安市人,在读硕士研究生,主要从事代谢性疾病方面的研究。
  • 基金资助:
    国家自然科学基金项目(82260126);国家自然科学基金项目(32460221);兵团指导性科技计划项目(2024ZD020);新疆第二医学院科研项目(ZR202540)

Improvement effect of angiopoietin-like protein 6 on liver lipid accumulation induced by methionine- and choline-deficient diet in mice and its mechanism

Shengcong WEN1,Yaya DENG*,Xinge ZHANG,Jiayi HE#,Yumeng SUN*,Jingling ZHU1,Yongshun SONG2(),Yunhua ZHANG1()   

  1. 1.Key Laboratory of Xinjiang Endemic & Ethnic Diseases,Ministry of Education,Department of Biochemistry,School of Medicine,Shihezi University,Shihezi 832002,China
    2.Department of Clinical Laboratory,Central Hospital,Karamay City,Xinjiang Uygur Autonomous Region,Karamay 834000,China
  • Received:2025-10-18 Accepted:2025-12-02 Online:2026-07-28 Published:2026-07-27
  • Contact: Yongshun SONG,Yunhua ZHANG E-mail:1521003011@qq.com;yunhuazhang@shzu.edu.cn

摘要:

目的 探讨血管生成素样蛋白6(ANGPTL6)对蛋氨酸和胆碱缺乏(MCD)饮食诱导的小鼠肝脏脂质沉积的改善作用,并阐明其可能的作用机制。 方法 将42只6周龄C57BL/6小鼠随机分为对照组、模型组和ANGPTL6过表达组(ANGPTL6组),每组14只。适应性饲养1周后,对照组小鼠正常饮食喂养,模型组和ANGPTL6组小鼠采用MCD饲料喂养8周;并于MCD饮食后1周,经尾静脉分别向模型组和ANGPTL6组小鼠注射腺相关病毒8-型腺相关病毒(AAV8)-绿色荧光蛋白(GFP)空载体及AAV8-ANGPTL6过表达载体。以油酸(OA)与棕榈酸(PA)混合物诱导HepG2细胞脂肪变性模型,将细胞分为空载体对照组(BSA组)、模型组(OD组)、ANGPTL6处理组(OAD组)和哺乳动物雷帕霉素靶蛋白(mTOR)激动剂组(OAM组)。采用HE染色和油红O染色评估各组小鼠肝组织形态及脂质沉积情况,试剂盒检测各组小鼠肝组织和各组HepG2细胞中总胆固醇(TC)及甘油三酯(TG)水平,实时荧光定量PCR(RT-qPCR)法检测各组小鼠肝组织和各组HepG2细胞中脂质代谢相关基因mRNA表达水平,Western blotting法检测各组小鼠肝组织和各组HepG2细胞中ANGPTL6、mTOR及磷酸化mTOR(p-mTOR)蛋白表达水平。 结果 与对照组比较,模型组和ANGPTL组小鼠肝脏出现严重的空泡样变性及脂质异常堆积,且肝组织中ANGPTL6蛋白表达水平降低(P<0.05)。与模型组比较,ANGPTL6组小鼠肝脏空泡样变性和脂质蓄积减轻,肝组织中TG水平降低(P<0.05),肝组织中脂质合成相关基因固醇调节元件结合蛋白1(SREBF1)和脂肪酸合成酶(FASN)mRNA表达水平均降低(P<0.05),脂质分解相关基因脂肪组织甘油三酯水解酶(ATGL)和肉碱棕榈酰转移酶1A(CPT1A)mRNA表达水平均升高(P<0.05);肝组织中mTOR和p-mTOR蛋白表达水平均降低(P<0.05)。与BSA组比较,OD组细胞中TG水平、FASN和乙酰辅酶A羧化酶α(ACACA)mRNA表达水平及mTOR和p-mTOR蛋白表达水平均升高(P<0.05);与OD组比较,OAD组细胞中TG水平、FASNACACA mRNA表达水平及mTOR和p-mTOR蛋白表达水平均降低(P<0.05);与OAD组比较,OAM组细胞中TG水平、FASNACACA mRNA表达水平及mTOR和p-mTOR蛋白表达水平均升高(P<0.05)。 结论 ANGPTL6可改善MCD饮食诱导的小鼠肝脏脂质沉积,其机制可能与抑制mTOR信号通路活性有关。

关键词: 血管生成素样蛋白6, 代谢相关脂肪性肝病, 哺乳动物雷帕霉素靶蛋白, 脂质代谢, 小鼠,C57BL/6

Abstract:

Objective To discuss the effect of angiopoietin-like protein 6 (ANGPTL6) on improving liver lipid accumulation induced by methionine- and choline-deficient (MCD) diet in the mice, and to clarify its possible mechanism. Methods Forty-two six-week-old C57BL/6 mice were randomly divided into control group, model group and ANGPTL6 overexpression group (ANGPTL6 group), with 14 mice in each group. After one week of adaptive feeding, the mice in control group were fed normal diet, and the mice in model group and ANGPTL6 group were fed with MCD diet for 8 weeks. One week after starting the MCD diet, adeno-associated virus serotype 8(AAV8)-green fluorescent protein (GFP) empty vector and AAV8-ANGPTL6 overexpression vector were injected into the mice in model group and ANGPTL6 group via the tail vein, respectively. The steatosis model in HepG2 cells was induced by a mixture of oleic acid(OA) and palmitic acid(PA), and the cells were divided into blank control group (BSA group), model group (OD group), ANGPTL6-treated group (OAD group) and mammalian target of rapamycin (mTOR) agonist group (OAM group). HE staining and oil red O staining were used to evaluate the liver tissue morphology and lipid deposition in the mice in various groups; kits were used to detect the levels of total cholesterol (TC) and triglyceride (TG) in liver tissue of the mice in various groups and in HepG2 cells in various groups; real-time fluorescence quantitative PCR (RT-qPCR) method was used to detect the mRNA expression levels of lipid metabolism-related genes in liver tissue of the mice in various groups and in HepG2 cells in various groups; Western blotting method was used to detect the expression levels of ANGPTL6, mTOR and phosphorylated mTOR (p-mTOR) proteins in liver tissue of the mice in various groups and in the HepG2 cells in various groups. Results Compared with control group, the livers of the mice in model and ANGPTL groups showed severe vacuolar degeneration and abnormal lipid accumulation, and the expression levels of ANGPTL6 protein in the liver tissue were decreased (P<0.05). Compared with model group, the vacuolar degeneration and lipid accumulation in liver tissue of the mice in ANGPTL6 group were alleviated, the TG level in liver tissue was decreased (P<0.05); the expression levels of lipid synthesis-related genes sterol regulatory element binding factor 1 (SREBF1) and fatty acid synthase (FASN) mRNA in liver tissue were decreased (P<0.05), and the expression levels of lipid decomposition-related genes adipose triglyceride lipase (ATGL) and carnitine palmitoyltransferase 1A (CPT1A) mRNA in liver tissue were increased (P<0.05); the expression levels of mTOR and p-mTOR proteins in liver tissue were decreased (P<0.05). Compared with BSA group, the TG level, the expression levels of FASN and acetyl-CoA carboxylase alpha (ACACA) mRNA, and the expression levels of mTOR and p-mTOR proteins in the cells in OD group were all increased (P<0.05); compared with OD group, the TG level, the expression levels of FASN and ACACA mRNA, and the expression levels of mTOR and p-mTOR proteins in the cells in OAD group were all decreased (P<0.05); compared with OAD group, the TG level, the expression levels of FASN and ACACA mRNA, and the expression levels of mTOR and p-mTOR proteins in the cells in OAM group were all increased (P<0.05). Conclusion ANGPTL6 can improve MCD diet-induced liver lipid accumulation in the mice, and its mechanism may be related to the inhibition of mTOR signaling pathway activity.

Key words: Angiopoietin-like protein 6, Metabolic dysfunction-associated fatty liver disease, Mammalian target of rapamycin, Lipid metabolism, Mice,C57BL/6

中图分类号: 

  • R363